首页> 外文期刊>The journal of alternative and complementary medicine: research on paradigm, practice, and policy >Concurrent use of corticosteroids with licorice-containing TCM preparations in Taiwan: a national health insurance database study.
【24h】

Concurrent use of corticosteroids with licorice-containing TCM preparations in Taiwan: a national health insurance database study.

机译:台湾同时使用皮质类固醇和含甘草的中药制剂:国家健康保险数据库研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: This study used a nationwide population-based dataset from the 1997-2003 National Health Insurance claims to explore the prevalence, frequency, and relative risk of concurrent use of systemic corticosteroids with licorice-containing Traditional Chinese Medicine (TCM) preparations that might possibly result in drug-herb interactions. DESIGN: This study was based on the complete datasets of Western medicine and TCM outpatient reimbursement claims from 1997 to 2003 contained in the National Health Insurance Research Database of Taiwan. According to the date and duration of prescriptions, the patients who concurrently used systemic corticosteroids with licorice-containing TCM preparations were derived for statistical analysis. SETTING: This study was set in Taiwan. OUTCOME MEASURES: Descriptive statistics were used to analyze the demographics of patients who used corticosteroids with licorice-containing TCM preparations concurrently, including age, gender, and the frequency and percentage of major diseases in International Classification of Diseases, 9th version, Clinical Modification (ICD-9-CM) categories. The relative risk of potential corticosteroid-herb interaction was also analyzed with respect to different characteristics of the patients (age, sexuality etc.). RESULTS: The prevalence of concurrent use of systemic corticosteroids with licorice-containing TCM preparations through prescriptions from different Chinese medicine and Western medicine physicians was 1.495%. Among the major disease categories, ICD-9-CM codes 280-289 had the highest prevalence rate of 3.803%. CONCLUSIONS: Potential risk of corticosteroid-licorice interactions may happen, even through formal medical services. In the future, such educational propagations should be reinforced. Furthermore, an alert device that includes well-recognized drug-herb interactions should be built into every hospital's computer system to remind physicians to be cautious on drug safety.
机译:目的:本研究使用了1997-2003年国家健康保险声明中的全国人群为基础的数据集,以探讨全身性糖皮质激素与含甘草的中药(TCM)制剂同时使用的发生率,频率和相对风险导致药草相互作用。设计:本研究基于台湾国家健康保险研究数据库中包含的1997年至2003年西医和中医门诊费用报销的完整数据集。根据处方的日期和持续时间,得出同时使用全身性皮质类固醇与含甘草的中药制剂的患者进行统计分析。地点:这项研究是在台湾进行的。观察指标:描述性统计资料用于分析同时使用皮质类固醇和含甘草中药制剂的患者的人口统计学信息,包括年龄,性别以及《国际疾病分类》(第9版,临床修改)中主要疾病的频率和百分比-9-CM)类别。还针对患者的不同特征(年龄,性别等)分析了潜在的皮质类固醇-药草相互作用的相对风险。结果:通过不同中医和西医医师的处方同时使用全身性皮质类固醇和含甘草的中药制剂的患病率为1.495%。在主要疾病类别中,ICD-9-CM代码280-289的最高患病率为3.803%。结论:即使通过正规的医疗服务,皮质类固醇-甘草相互作用的潜在风险也可能发生。将来,应该加强这种教育传播。此外,应在每家医院的计算机系统中内置包括公认的药草相互作用的警报设备,以提醒医生对药物安全性保持谨慎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号